Cargando…
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy
BACKGROUND: Despite recent advances, there is an urgent need for agents targeting HER2-expressing cancers other than breast cancer. We report a phase I study (NCT01730118) of a dendritic cell (DC) vaccine targeting HER2 in patients with metastatic cancer or bladder cancer at high risk of relapse. PA...
Autores principales: | Maeng, Hoyoung M., Moore, Brittni N., Bagheri, Hadi, Steinberg, Seth M., Inglefield, Jon, Dunham, Kim, Wei, Wei-Zen, Morris, John C., Terabe, Masaki, England, Lee C., Roberson, Brenda, Rosing, Douglas, Sachdev, Vandana, Pack, Svetlana D., Miettinen, Markku M., Barr, Frederic G., Weiner, Louis M., Panch, Sandhya, Stroncek, David F., Wood, Lauren V., Berzofsky, Jay A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716407/ https://www.ncbi.nlm.nih.gov/pubmed/34976830 http://dx.doi.org/10.3389/fonc.2021.789078 |
Ejemplares similares
-
Strategies for developing and optimizing cancer vaccines
por: Maeng, Hoyoung M., et al.
Publicado: (2019) -
Identification of genomic signatures in bone marrow associated with clinical response of CD19 CAR T-cell therapy
por: Shao, Lipei, et al.
Publicado: (2022) -
The need for uniform and coordinated practices involving centrally manufactured cell therapies
por: Stroncek, David, et al.
Publicado: (2022) -
Tissue-Specific Roles of NKT Cells in Tumor Immunity
por: Terabe, Masaki, et al.
Publicado: (2018) -
Balance is a key for happiness
por: Izhak, Liat, et al.
Publicado: (2013)